Livzon Pharmaceutical Group Inc
SZSE:000513
Livzon Pharmaceutical Group Inc
SZSE:000513
Price:
39.28 CNY
-1.06%
Market Closed
Updated:
May 18, 2024
Livzon Pharmaceutical Group Inc
Operating Expenses
|
Livzon Pharmaceutical Group Inc
Operating Expenses Peer Comparison
Comparables:
H
3692
600436
600276
000538
S
688506
Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Livzon Pharmaceutical Group Inc
SZSE:000513
|
Operating Expenses
-¥5.6B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-9%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Expenses
-¥6.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Expenses
-¥1.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-17%
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Expenses
-¥14.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-15%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Expenses
-¥6.6B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-12%
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Operating Expenses
-¥1.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Livzon Pharmaceutical Group Inc's Operating Expenses?
Operating Expenses
-5.6B
CNY
-5.6B
CNY
Based on the financial report for Mar 31, 2024, Livzon Pharmaceutical Group Inc's Operating Expenses amounts to -5.6B CNY.
What is Livzon Pharmaceutical Group Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-9%
-9%
Over the last year, the Operating Expenses growth was 3%. The average annual Operating Expenses growth rates for Livzon Pharmaceutical Group Inc have been -4% over the past three years , -5% over the past five years , and -9% over the past ten years .
You don't have any saved screeners yet
